{"transactions":[{"id":724392,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34867,"kind":"person","name":"Chavez Margarita","position":1,"cik":"0002032496","reported_name":"Chavez Margarita","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-29T20:37:59.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":5.5,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-26-000304","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032496/000161071726000304/form4.xml","form_type":"4"}},{"id":1101196,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34867,"kind":"person","name":"Chavez Margarita","position":1,"cik":"0002032496","reported_name":"Chavez Margarita","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:29:46.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2026 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":7.63,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-25-000255","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032496/000161071725000255/form4.xml","form_type":"4"}},{"id":1437082,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34867,"kind":"person","name":"Chavez Margarita","position":1,"cik":"0002032496","reported_name":"Chavez Margarita","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-09T20:09:21.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares vest in thirty-six (36) successive and equal monthly installments measured from August 7, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":120000,"derivative":{"exercise_price":0.55,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001610717-24-000423","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032496/000161071724000423/form4.xml","form_type":"4"}}]}